Show Summary Details
Page of

Management of the Patients with Spinal Cord Stimulators and Intrathecal Pumps 

Management of the Patients with Spinal Cord Stimulators and Intrathecal Pumps
Chapter:
Management of the Patients with Spinal Cord Stimulators and Intrathecal Pumps
Author(s):

Samuel W. Samuel

and Khodadad Namiranian

DOI:
10.1093/med/9780199349302.003.0023
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 October 2019

Abstract: This chapter describes management of patients with intrathecal pumps, spinal cord stimulators, and other implanted devices used for treating chronic pain. Except for the intrathecal baclofen pump, all other implantable devices are used mainly for pain control; their cessation will not result in a life-threatening situation. The symptoms of baclofen overdose range from dizziness and drowsiness to respiratory depression, hypothermia, seizures, hypotonia, and coma. Symptoms of baclofen withdrawal range from seizures to muscle rigidity that advances to rhabdomyolysis, multiple organ failure, and death. Spinal cord stimulators can be turned off before a procedure and turned on at the end of it. Intrathecal pump infusion can be continued during the surgery and the postoperative pain regimen must be supplemented with other methods for analgesia. Implantable devices must be protected from electrocautery per manufacturer’s recommendation. Generally, MRI interferes with some spinal cord stimulators, but patients with intrathecal pumps can be exposed to MRI with strength of magnetic field up to 1.5 Tesla.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.